Literature DB >> 12608631

Effect of ginsenoside Rb1 on long-term potentiation in the dentate gyrus of anaesthetized rats.

Xiao-Ying Wang1, Jun-Tian Zhang.   

Abstract

Ginsenosides are the major principles of Panax ginseng and have various pharmacological actions on the central nervous system. In this report, we investigated whether ginsenoside Rb1 (10, 100 nmol(-1), icv) could increase the population spike (PS) amplitude in a dose-dependent manner, and accelerate the maintenance phase of long-term potentiation (LTP) induced by high frequency stimulation (HFS) in the dentate gyrus of anaesthetized rats. However, it had no effect on basic synaptic responses evoked by test stimulation. Comparatively, ginsenoside Rb1 (10, 100 nmol l(-1), icv) inhibited the induction phase of LTP induced by HFS in a dose-dependent manner. This may be one of the mechanisms of action of ginsenoside Rb1 on synaptic transmission. The details of the mechanism need further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608631     DOI: 10.1080/10286020290029009

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  4 in total

1.  Co-transformation of Panax major ginsenosides Rb₁ and Rg₁ to minor ginsenosides C-K and F₁ by Cladosporium cladosporioides.

Authors:  Lunpeng Wu; Yan Jin; Chengri Yin; Longlv Bai
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-20       Impact factor: 3.346

2.  Biotransformation of ginsenosides Rb1, Rg3 and Rh2 in rat gastrointestinal tracts.

Authors:  Tianxiu Qian; Zongwei Cai
Journal:  Chin Med       Date:  2010-05-26       Impact factor: 5.455

3.  A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.

Authors:  Hee Jin Kim; Pitna Kim; Chan Young Shin
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

Review 4.  Recent advances in the study of (-)clausenamide: chemistry, biological activities and mechanism of action.

Authors:  Shi-Feng Chu; Jun-Tian Zhang
Journal:  Acta Pharm Sin B       Date:  2014-11-20       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.